申请人:CASE WESTERN RESERVE UNIVERSITY
公开号:US11129845B2
公开(公告)日:2021-09-28
A compound comprising formula (I):
wherein R1 is an akylamino group or a group containing at least one aromatic group;
R2 and R3 are independently an aliphatic group or hydrophobic group;
R4 and R5 are independently H, a substituted or unsubstituted akyl group, an akenyl group, an acyl group, an aromatic group, polymer, a targeting group, or a detectable moiety;
a, b, c, and d are independently an integer from 1 to 10; and pharmaceutically acceptable salts thereof.
由式 (I) 组成的化合物:
其中 R1 是烷基氨基或含有至少一个芳香族基团的基团;
R2 和 R3 独立地是脂肪族基团或疏水基团;
R4 和 R5 独立地为 H、取代或未取代的烷基、烯基、酰基、芳香基、聚合物、靶向基团或可检测分子;
a、b、c 和 d 独立地为 1 至 10 的整数;及其药学上可接受的盐。